Researchers at Trinity College Dublin, in collaboration with Breye Therapeutics, have found that an oral medication (“Danegaptide”) can protect against vision-threatening damage in Non-Proliferative Diabetic Retinopathy (NPDR), which is a leading cause of blindness in working-age adults. The study, published today in leading international journal,  Science Translational Medicine, highlights a new therapeutic approach that could replace or complement frequent, highly invasive eye injections for millions of patients with diabetes.

People born preterm are likely to be less physically active as teenagers and adults, according to large Norwegian study which measured a week of participants' activity using wearable sensors

The Gerontological Society of America (GSA) invites journalists to attend its 2026 Annual Scientific Meeting — the country’s largest interdisciplinary conference in the field of aging — from November 4 to 7 in National Harbor, Maryland. Qualified media representatives intending to cover the meeting may register free of charge.

Stable employment in midlife was associated with better cognitive health in later life, according to a new study from Columbia University Mailman School of Public Health’s Butler Aging Center. Conversely, employment instability, early retirement, and dropping out of the labor force are linked to significantly poorer cognitive outcomes. The findings are published in Alzheimer’s & Dementia.

A systematic review of the scientific literature on mobile phone use during pregnancy and fetal outcomes examines the potential health effects of mobile phone exposure during pregnancy. While some studies included in the review found no significant association between short- or long-term mobile phone use and major pregnancy outcomes, most studies associated prolonged or intensive use with a range of adverse outcomes, particularly cardiovascular abnormalities and shorter gestational duration.  The findings are published in Nature’s Journal of Exposure Science & Environmental Epidemiology.

About the Study: Among patients with moderate to severe basilar artery occlusion admitted directly to EVT-capable centers who presented 4.5 to 24 hours after stroke onset, the addition of intravenous tenecteplase before EVT did not result in improved functional outcomes compared with EVT alone.